Immunohistochemical analyses of PY Shc and p66 Shc were performed on archival primary breast cancer tumors from a population based cohort 60 patients, 9 relapses and, for validation, an independent external cohort 31 patients, 13 relapses in which all patients received tamoxifen as a sole systemic adjuvant prior to relapse <a href=http://cialis.lat/discover-the-best-prices-for-cialis>buy cialis generic</a>
Статья
Обсуждение